These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 24056936)
1. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936 [TBL] [Abstract][Full Text] [Related]
2. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812 [TBL] [Abstract][Full Text] [Related]
3. Structural features of β2 adrenergic receptor: crystal structures and beyond. Bang I; Choi HJ Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861 [TBL] [Abstract][Full Text] [Related]
4. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Rasmussen SG; Choi HJ; Fung JJ; Pardon E; Casarosa P; Chae PS; Devree BT; Rosenbaum DM; Thian FS; Kobilka TS; Schnapp A; Konetzki I; Sunahara RK; Gellman SH; Pautsch A; Steyaert J; Weis WI; Kobilka BK Nature; 2011 Jan; 469(7329):175-80. PubMed ID: 21228869 [TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
6. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist. Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744 [TBL] [Abstract][Full Text] [Related]
8. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234 [TBL] [Abstract][Full Text] [Related]
9. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? Tang H; Wang XS; Hsieh JH; Tropsha A Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072 [TBL] [Abstract][Full Text] [Related]
10. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor. Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065 [TBL] [Abstract][Full Text] [Related]
11. Single-molecule analysis of ligand efficacy in β Gregorio GG; Masureel M; Hilger D; Terry DS; Juette M; Zhao H; Zhou Z; Perez-Aguilar JM; Hauge M; Mathiasen S; Javitch JA; Weinstein H; Kobilka BK; Blanchard SC Nature; 2017 Jul; 547(7661):68-73. PubMed ID: 28607487 [TBL] [Abstract][Full Text] [Related]
12. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ; Leurs R; de Esch IJ; de Graaf C J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966 [TBL] [Abstract][Full Text] [Related]
13. Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876 [TBL] [Abstract][Full Text] [Related]
14. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554 [TBL] [Abstract][Full Text] [Related]
15. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Warne T; Moukhametzianov R; Baker JG; Nehmé R; Edwards PC; Leslie AG; Schertler GF; Tate CG Nature; 2011 Jan; 469(7329):241-4. PubMed ID: 21228877 [TBL] [Abstract][Full Text] [Related]
16. Structural insights into binding specificity, efficacy and bias of a β Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561 [TBL] [Abstract][Full Text] [Related]
17. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators. Reynolds KA; Katritch V; Abagyan R J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
19. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations. Feng Z; Hou T; Li Y J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225 [TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Positive Allosteric Modulators of the Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]